Navigation Links
Helix BioPharma Corp. contracts KBI Biopharma to develop an L-DOS47 clinical packaging format
Date:1/16/2008

ation ("FDA") to conduct a Phase I clinical study with L-DOS47 in lung adenocarcinoma patients.

About KBI BioPharma

KBI Biopharma Inc. is a contract biopharmaceutical development organization offering a full range of preformulation/formulation development, analytical method development and validation, full process development and clinical manufacturing (for both mammalian and microbial programs). Services are carried out in state-of-the-art laboratories housed in Durham, North Carolina. More information can be obtained from http://www.kbibiopharma.com.

About Helix BioPharma Corp.

Helix BioPharma Corp. is a biopharmaceutical company specializing in the field of cancer therapy. The company is actively developing innovative products for the prevention and treatment of cancer based on its proprietary technologies. Helix's product development initiatives include its Topical Interferon Alpha-2b and its novel L-DOS47 new drug candidate. Helix is listed on the TSX under the symbol "HBP" and quoted on the Frankfurt, Berlin, Munich and Stuttgart Stock Exchanges under the same symbol.

The Toronto Stock Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this News Release. Helix has relied solely on KBI Biopharma for the information about KBI Biopharma provided in this News Release and Helix disclaims any liability with respect to such information. Helix disclaims responsibility for information contained in any linked or referenced website, and such links and references do not constitute an endorsement by Helix of those or any other website. This News Release contains forward-looking statements and information regarding production of L-DOS47, a planned Phase I clinical study, and products under development, which statements can be identified by the words "will", "potential", "is thought", "is believed", "intends", and "developing". A
'/>"/>

SOURCE Helix BioPharma Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor
2. Helix BioPharma Chairman resigns
3. Helix BioPharma Corp. announces fiscal 2007 results
4. Helix BioPharma Corp. announces management changes
5. Helix BioPharma announces $16.9 million private placement of common shares
6. Helix BioPharma announces Q1 2008 financial results
7. Helix BioPharma closes $16.9 million private placement of common shares
8. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
9. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
10. PDL BioPharma Announces Internal CEO Investigation Found No Credible Evidence of Improper Personal Conduct or Breach of Fiduciary Duty
11. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2008)...hould Die of Diabetes, BRUSSELS, October 13 /PRNe...IDF) announced today that it is bringing together ...are for the thousands of children,with diabetes in...e meeting, Access to Essential Diabetes Medicines ... on Saturday, October 25 in London, United,Kingdom...
(Date:10/13/2008)...wswire-FirstCall/ -- Thursday and Friday of,last w...ic,s (NYSE: BSX ),stock. As anticipated in the Co...rtion of this trading was due to involuntary sales...,s co-founders Pete Nicholas and,John Abele. As of...31,million shares in aggregate had been sold last ...
(Date:10/13/2008)... /- WebLOQ, Inc., the emerging,leader...nt eBusiness and,data-in-motion communications, to...ployed the WebLOQ ePrivacy solution in their state...h their healthcare partner, the,Monterey Peninsula...plemented WebLOQ,s hosted, on demand ePrivacy tech...
(Date:10/13/2008)...ctober 13 /-,Following fulf...as now,completed the acquisition* of all outstandi... in prescription optical equipment., Satisloh des...surfacing,machines, as well as consumables, for pr...n in revenue in 2007 and employs more than 400 peo...
Breaking Biology Technology:International Diabetes Federation Calls for Global Action to Keep All Children With Diabetes Alive 2International Diabetes Federation Calls for Global Action to Keep All Children With Diabetes Alive 3Boston Scientific Provides Update on Involuntary Selling of Its Stock by Co-Founders 2Boston Scientific Provides Update on Involuntary Selling of Its Stock by Co-Founders 3Monterey Spine and Joint Deploys WebLOQ ePrivacy Solution for HIPAA Compliant Health Information Exchange 2Monterey Spine and Joint Deploys WebLOQ ePrivacy Solution for HIPAA Compliant Health Information Exchange 3
...rs Note: Wisconsins Department of Workforce Deve...gthening the states workforce. The department has ...bs, increase wages, address workforce shortages an...o Wisconsin workers. Secretary Roberta Gassman in ... talks about how DWD is investing in people and ho...
...EE-- ARI , a provider of business solutions that c...and distribution networks, announced today that Ha...t to license ARI,s EMPARTweb e-Catalog solution fo...okup and ordering service within their dealer webs...web, provide ongoing updates for selected manufact...
...eld, Wis.-- Fiserv Credit Processing Services se...t solutions to help ensure response time of its cr... Fiserv Credit Processing Services provides outso...s a unit of Fiserv, Inc. , ,Fiserv Credit Processi...enhances their ability to manage credit decisions,...
...s suggest 1500 Megawatts of Electricity Could Be S...e Wisconsin, especially after the California Energ... paradigm shift. There was a time when the major p...d with the utilities, the federal government and i...the environmental component of each decision made ...
Other Biology Technology:WTN Interview: Roberta Gassman 2WTN Interview: Roberta Gassman 3Wisconsins Businesses Can Become Environmental Leaders 2Wisconsins Businesses Can Become Environmental Leaders 3
(Date:10/12/2008)...built-in weapon against HIV, but until recently no... published online by the journal Nature reveals ...wn as APOBEC-3G and suggests new directions for d... human cell. It is capable of stopping HIV at the ...nscribes its RNA into viral DNA. , The study,s a...
(Date:10/10/2008)...formation technology have shaped not only how we f... medicines. A project just funded by the National ...drug design to the next level. , The University ...ance the molecular data needed to develop computer...rug candidates. The data will be housed in a Web-b...
(Date:10/10/2008)...om the Peninsula Medical School in Plymouth, UK, h...r of moderate exercise a day recommended to childr... the rising problem of childhood obesity. , Thei...ssue of the journal "Archives of Diseases in Child...dy, which has followed the development of over 200...
(Date:10/10/2008)...is available in German . , DNA, the molecule ... all forms of life, is highly resistant against al...he mechanism for its photostability presents some ... between the four chemical bases that make up the ...succeeded in showing that DNA strands differ in th...
Breaking Biology News(10 mins):Body's anti-HIV drug explained 2New data resource to advance computer-aided drug design 2Recommendations for children's exercise lacking say experts 2Can genetic information be controlled by light? 2Age alone should not be used to determine whether to treat prostate cancer with hormones 26740 1Age alone should not be used to determine whether to treat prostate cancer with hormones 26740 2Age alone should not be used to determine whether to treat prostate cancer with hormones 26740 3Lilly to Sponsor Congressional Black Caucus Foundations Annual Legislative Conference 26734 1Lilly to Sponsor Congressional Black Caucus Foundations Annual Legislative Conference 26734 2Lilly to Sponsor Congressional Black Caucus Foundations Annual Legislative Conference 26734 3LodgeNet Healthcare Signs New Agreement with NorthShore University HealthSystem 26729 1LodgeNet Healthcare Signs New Agreement with NorthShore University HealthSystem 26729 2LodgeNet Healthcare Signs New Agreement with NorthShore University HealthSystem 26729 3New Report on 633 Biotechnology Medicines Under Development Released in Michigan 7901 1New Report on 633 Biotechnology Medicines Under Development Released in Michigan 7901 2New Report on 633 Biotechnology Medicines Under Development Released in Michigan 7901 3
... experiments of their kind, researchers at Rice Un...n Cancer Center have determined that carbon nanotu...arch lab animals cause no immediate adverse health...re they are removed by the liver. , The findings a...ly unmodified carbon nanotubes, a revolutionary na...
...mal model, brain researchers in Göttingen have exa...n humans. These are mutations in the genes which c... neuroligin family. The study published in the sci...that neuroligins ensure that signal transmission b...tically altered mice without neuroligins, the cont...
... for targeting malignant brain tumors through indu...een developed by a team of researchers headed by a...emistry. , Alexander Levitzki, who is the Wolfs...associate, Dr. Alexei Shir, and his colleagues fro...many, have pioneered a technique in which a molecu...
...us previously used as a marker in tracing human mi...s at Penn State. Results of this study also sugges...r rates of evolution than previously thought. , "T...e in Africa," said Laura Shackelton, a postdoctora... Disease Dynamics. "But, in the case of this virus...
Other Biology News:Pure carbon nanotubes pass first in vivo test 2When nerve cells can't make contact 2When nerve cells can't make contact 3When nerve cells can't make contact 4 Killing brain tumors from within: A 'Trojan horse' approach 2Viral marker of human migration suspect 2
...ly Gradient thermal cycler which enables you to op... ,Wide linear gradient - The most linear gradient...C. Protocols can be optimised in a single experime...orates a large, 115 x 90mm, touch-sensitive screen...
... with a comprehensive array of accessories. JULAB...s, splash-water protected keypad offer a high oper...cating up to 6 temperature values is visible from ... with PID temperature control eliminates temperatu...
...abilizer is an aqueous solution that contains a pu...ing chemicals in a MOPS buffer (3-(N-Morpholino) p...ontains a combination of 0.02% methylisothiazolone...Rohm and Haas Company) as a preservative. StabilZ...
Request Info
Biology Products: